EC Number   |
Specific Activity Minimum [µmol/min/mg] |
Specific Activity Maximum [µmol/min/mg] |
Reference |
|---|
   3.1.1.52 | -999 |
- |
5fold increase in specific activity of activated platelet-derived wild-type and phosphorylated forms in presence of 10 mol% phosphatidylinositol 4,5-biphosphate |
693262 |
| 3.1.1.52 | 0.21 |
- |
mutant K271N/K273N/K274N, from activated platelets |
693262 |
| 3.1.1.52 | 0.23 |
- |
wild-type, from activated platelets |
693262 |
| 3.1.1.52 | 0.26 |
- |
phoshorylated at residue S515, from activated platelets |
693262 |
| 3.1.1.52 | 0.38 |
- |
phoshorylated at residue S505, from activated platelets |
693262 |
| 3.1.1.52 | 0.39 |
- |
mutant K488N/K543N/K544N, from activated platelets, in presence of 10 mol% phosphatidylinositol 4,5-biphosphate |
693262 |
| 3.1.1.52 | 0.4 |
- |
mutant K488N/K543N/K544N, from activated platelets |
693262 |
| 3.1.1.52 | 0.405 |
- |
phosphorylated at residues S505 and S727, from activated platelets |
693262 |
| 3.1.1.52 | 0.68 |
- |
mutant K271N/K273N/K274N, from activated platelets, in presence of 10 mol% phosphatidylinositol 4,5-biphosphate |
693262 |
| 3.1.1.52 | 0.742 |
- |
- |
80966 |
